Cliff Asness’s The First Bancshares, Inc. FBMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-37,667
Closed -$1.27M 3430
2025
Q1
$1.27M Sell
37,667
-5,057
-12% -$181K ﹤0.01% 1868
2024
Q4
$1.5M Buy
42,724
+2,193
+5% +$76.4K ﹤0.01% 1677
2024
Q3
$1.3M Sell
40,531
-27,813
-41% -$861K ﹤0.01% 1720
2024
Q2
$1.78M Buy
68,344
+23,747
+53% +$585K ﹤0.01% 1504
2024
Q1
$1.16M Buy
44,597
+37,439
+523% +$962K ﹤0.01% 1630
2023
Q4
$210K Buy
+7,158
New +$191K ﹤0.01% 2198
2023
Q1
Sell
-32,883
Closed -$1.05M 2270
2022
Q4
$1.05M Sell
32,883
-6,941
-17% -$225K ﹤0.01% 1544
2022
Q3
$1.19M Buy
39,824
+4,224
+12% +$126K ﹤0.01% 1442
2022
Q2
$1.02M Buy
35,600
+17,255
+94% +$536K ﹤0.01% 1420
2022
Q1
$617K Buy
18,345
+10,244
+126% +$372K ﹤0.01% 1737
2021
Q4
$313K Buy
+8,101
New +$323K ﹤0.01% 1969
2020
Q4
Sell
-10,329
Closed -$217K 2274
2020
Q3
$217K Buy
+10,329
New +$219K ﹤0.01% 2035
2018
Q4
Sell
-8,519
Closed -$333K 2296
2018
Q3
$333K Buy
8,519
+2,731
+47% +$107K ﹤0.01% 2079
2018
Q2
$208K Buy
+5,788
New +$195K ﹤0.01% 2212

Other funds holding FBMS

Cliff Asness's FBMS Position: Q2 2025 in Review

Cliff Asness sold out of The First Bancshares, Inc. (FBMS) in Q2 2025, closing a stake of 37,667 shares — an estimated $1.27M sold.

Cliff Asness first reported a position in FBMS in Q2 2018 and held it in 14 quarters. The position peaked at $1.78M in Q2 2024. 1 fund tracked by Wall St. Rank holds FBMS as of Q2 2025.

  • Cliff Asness reported no remaining The First Bancshares, Inc. position as of Q2 2025 after selling out during the quarter.
  • Cliff Asness sold 37,667 The First Bancshares, Inc. shares in Q2 2025, an estimated $1.27M.
  • Cliff Asness first reported a position in The First Bancshares, Inc. in Q2 2018 and held it in 14 quarters.
  • Cliff Asness's The First Bancshares, Inc. position peaked at $1.78M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held The First Bancshares, Inc. as of Q2 2025.

Based on AQR Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.